Many professionals encounter resistance when explaining why Quality should provide the final approval signature on regulated documents governed by a Quality Management System (QMS). Although the Code of Federal Regulations (CFR) does not explicitly state that Quality must sign last, the regulatory framework establishes responsibilities for the Quality function, requirements for compliant approvals and signatures, and conditions under which controlled records may be approved.
Together, these expectations help explain the long-standing industry practice of positioning Quality as the final approval step. The practice is best understood as a risk-based QMS control rather than a universal regulatory mandate.
The Regulatory Role of Quality
Within a regulated QMS, Quality has an oversight role in ensuring that applicable requirements are satisfied and that controlled documentation is complete, accurate, appropriately reviewed, and compliant before release or use.
This oversight function commonly includes confirming that required technical and functional reviews have occurred, procedural requirements have been followed, identified risks have been appropriately addressed, and the document is ready to enter its approved state.
What an Approval Signature Represents
Electronic-record and electronic-signature requirements reinforce the importance of controlled approvals. Under 21 CFR Part 11, electronic signatures must be attributable to the individual signer and linked to the associated electronic record.
The meaning of a signature should also be clear within the approval workflow. Depending on the signer’s role, an approval may represent technical review, process ownership, regulatory review, Quality approval, or authorization for release. The significance of the signature therefore depends not only on who signs, but also on what that approval means within the organization’s documented process.
Why Quality Commonly Signs Last
Placing Quality at the end of the approval sequence allows the Quality function to perform a final compliance-oriented review after the required technical, functional, and process-owner reviews have been completed.
In this model, the final Quality approval can confirm that:
· Required reviewers have completed their approvals.
· The document is complete and internally consistent.
· Applicable QMS procedures and document-control requirements have been followed.
· Identified compliance or quality risks have been appropriately addressed.
· The document is suitable for controlled release or use.
This sequencing creates a clear approval gate between document development and controlled release.
Quality Approval as a Release Control
The strongest rationale for Quality signing last is not that a regulation explicitly requires a particular signature order. Rather, final Quality approval can function as a release control within the QMS.
When the organization defines Quality approval this way in its procedures, the signature provides documented evidence that the prescribed review process has been completed before the document becomes effective or is released for regulated use. This supports traceability, accountability, and record integrity.
Regulatory Requirement vs. Industry Practice
It is important to distinguish regulatory requirements from organizational practice. Regulations establish expectations for effective quality-system controls, appropriate review and approval, record integrity, and—where applicable—electronic signatures. They generally do not prescribe a universal rule stating that the Quality department must always be the final signatory on every regulated document.
The approval sequence should therefore be defined by the organization’s QMS procedures based on document type, regulatory requirements, roles and responsibilities, risk, and the intended meaning of each approval.
When Quality May Not Need to Sign Last
A Quality-last sequence may not be necessary for every document. Some records may require final authorization by a designated management representative, regulatory function, technical authority, process owner, or other accountable role.
What matters is that the approval workflow is clearly defined, consistently followed, appropriately controlled, and capable of demonstrating that all required reviews occurred before release. If Quality is assigned final compliance or release authority by procedure, placing Quality last is a logical and defensible control.
Conclusion: Quality Signing Last Is a Control, Not a Universal Mandate
Quality commonly signs last because this sequence provides an effective final checkpoint for confirming that required reviews are complete and that a document is ready for controlled release. It aligns naturally with Quality’s oversight responsibilities and supports record integrity, traceability, and risk reduction.
However, the distinction is important: “Quality signs last” is generally an industry practice and procedural control—not a blanket statement explicitly mandated by 21 CFR. Organizations should define approval sequencing within their QMS based on regulatory obligations, risk, document type, and assigned authority.
References
21 CFR § 820.20 – Management Responsibility.
FDA. Quality Management System Regulation (QMSR).
21 CFR Part 11 – Electronic Records; Electronic Signatures.
FDA. Medical Device Premarket Approval and Postmarket Inspections – Inspectional guidance.